A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Arun J Sanyal, MD
VCU Health, Gastroenterology Hepatology and Nutrition, 1200 West Broad Street, Richmond VA23298, USA
Principal InvestigatorKOL profile → - Sven Francque, MD
Division of Gastroenterology and Hepatology, Antwerp University Hospital, Wilrijkstraat 10, B-2650 Edegem, Belgium
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
459 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital Británico de Buenos Aires
Buenos Aires, Buenos Aires, Argentina
- Hospital de Alta Complejidad En Red El Cruce
Buenos Aires, Buenos Aires, Argentina
- Hospital Italiano de Buenos Aires
Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
- Hospital Italiano la Plata
La Plata, Buenos Aires, Argentina
- Hospital Universitario Austral
Pilar, Buenos Aires, Argentina
- Hospital Provincial del Centenario
Rosario, Santa Fe Province, Argentina
- Concord Repatriation General Hospital
Concord, New South Wales, Australia
- Campbelltown Hospital
Liverpool, New South Wales, Australia
- Liverpool Hospital
Liverpool, New South Wales, Australia
- Nepean Hospital
Penrith, New South Wales, Australia
- Gallipoli Medical Research Foundation
Greenslopes, Queensland, Australia
- Royal Brisbane and Women'S Hospital
Herston, Queensland, Australia
- Eastern Health - Australia
Box Hill, Victoria, Australia
- Monash Medical Centre
Clayton, Victoria, Australia
- Austin Health
Heidelberg, Victoria, Australia
- Fiona Stanley Hospital
Murdoch, Western Australia, Australia
- Royal Perth Hospital
Perth, Western Australia, Australia
- Universitair Ziekenhuis Antwerpen
Edegem, Antwerpen, Belgium
- Cliniques Universitaires Saint-Luc
Brussels, Brussels Capital, Belgium
- Hôpital Erasme
Brussels, Brussels Capital, Belgium
- Universitair Ziekenhuis Leuven - Campus Gasthuisberg
Leuven, Flemish Brabant, Belgium
- Ziekenhuis Oost-Limburg - Campus Sint-Jan
Genk, Limburg, Belgium
- Centre Hospitalier Universitaire de Liège Site Sart Tilman
Liège, Liège, Belgium
- Algemeen Ziekenhuis Maria Middelares
Ghent, Oost-Vlaaderen, Belgium
- Universitair Ziekenhuis Gent
Ghent, Oost-Vlaanderen, Belgium
- Vitaz
Sint-Niklaas, Oost-Vlaanderen, Belgium
- Algemeen Ziekenhuis Delta - Campus Rumbeke
Roeselare, West-Vlaanderen, Belgium
- Hospital Das Clinicas Da Universidade Federal de Minas Gerais
Belo Horizonte, Minas Gerais, Brazil
- Hospital de Clínicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil
- Hospital Das Clínicas Da Faculdade de Medicina Da Universidade de São Paulo
Cerqueira César, São Paulo, Brazil
- Hospital Das Clínicas Da Faculdade de Medicina de Ribeirão Preto
Ribeirão Preto, São Paulo, Brazil
- Fundação Faculdade Regional de Medicina de São José Do Rio Preto
São José do Rio Preto, São Paulo, Brazil
- Acibadem City Clinic Tokuda Hospital
Sofia, Sofia, Bulgaria
- Diagnostic Consultative Center Aleksandrovska
Sofia, Sofia, Bulgaria
- Diagnostic Consulting Center 20 - Sofia Еооd
Sofia, Sofia, Bulgaria
- University Multiprofile Hospital for Active Treatment St. Ivan Rilski
Sofia, Sofia-Grad, Bulgaria
- University Multiprofile Hospital for Active Treatment and Emergency Medicine N.I. Pirogov
Sofia, Sofia-Grad, Bulgaria
- Medical Center Medica Plus
Veliko Tarnovo, Veliko Tarnovo, Bulgaria
- Heritage Medical Research Centre
Calgary, Alberta, Canada
- William Osler Health System - Brampton Civic Hospital
Brampton, Ontario, Canada
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 19 Aug 2021
- Primary completion
- 30 Sept 2027
- Completion
- 30 Sept 2027
- Last update posted
- 2 Jul 2026
- Registered enrollment
- 1,000
- Registry id
- NCT04849728
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.